| abstract |
The subject of the invention is the genomic sequence and nucleotide sequences coding for circovirus MAP polypeptides, such as the structural and non-structural polypeptides of said circovirus, as well as vectors including said sequences and cells or animals transformed with these vectors. The invention also relates to methods for detecting such nucleic acids or polypeptides and diagnostic kits for circovirus MAP infection. The invention also provides a method of selecting compounds capable of modulating viral infection. The invention finally comprises pharmaceutical compositions, especially vaccine, for the prevention and / or treatment of viral infections by Circovirus MAP as well as the use of vector according to the invention for the prevention and / or treatment of diseases by therapy gene. |